Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
SITC
Incyte
ChemoCentryx
Amgen
cytokines
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Amgen CEO Robert Bradway warns Biden's Inflation Reduction Act could blunt future biotech success stories
Fierce Pharma
Thu, 09/15/22 - 11:22 pm
Amgen
Bob Bradway
Pharma CEOs
Inflation Reduction Act
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
ESMO
KRAS inhibitors
Relay Therapeutics
Regeneron
Amgen
Deciphera
Clovis Oncology
Ayala Pharmaceuticals
Springworks
Mirati Therapeutics
ESMO: Amgen's Lumakras confirmatory lung cancer data are here, fanning KRAS battle flames
Fierce Pharma
Sun, 09/11/22 - 11:07 pm
Amgen
lung cancer
ESMO
KRAS inhibitors
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
Motley Fool
Fri, 09/9/22 - 10:57 am
Amgen
Soliris
biosimilars
ABP 959
Amgen's Neulasta gains another biosimilar competitor as sales slip
Endpoints
Thu, 09/8/22 - 04:35 pm
Amgen
Neulasta
Fresenius Kabi
biosimilars
FDA
Stimufend
Amgen’s Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod
MedCity News
Wed, 08/31/22 - 10:23 am
Amgen
Lumakras
non-small cell lung cancer
clinical trials
Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe
Fierce Pharma
Fri, 08/12/22 - 10:17 am
Amgen
taxes
IRS
Senate
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
clinical trials
psoriasis
psoriatic arthritis
Lipidor
AKP-02
Amgen
ABP-654
Hengyi
HPP-737
Galapagos
Jyseleca
World Lung – Toxicity scuppers Amgen’s first-line lung hopes
EP Vantage
Mon, 08/8/22 - 09:53 am
Amgen
World Lung
Lumakras
non-small cell lung cancer
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Amgen
BCMA
PSMA
Multiple Myeloma
bispecific antibodies
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Fierce Pharma
Thu, 08/4/22 - 12:10 pm
Amgen
M&A
patent cliff
ChemoCentryx
Weeks after starting, Amgen flashes yellow light on PhIII of $400M eczema bet
Endpoints
Thu, 08/4/22 - 11:03 am
Amgen
Kyowa Kirin
clinical trials
AMG 451
atopic dermatitis
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol
Big Pharmas Amgen, BMS shield BigHat from stormy market with $75M funding
Fierce Biotech
Wed, 07/20/22 - 10:01 am
BigHat Biosciences
funding
Amgen
Bristol Myers Squibb
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Endpoints
Tue, 07/19/22 - 10:01 pm
Amgen
GSK
Regenxbio
Supreme Court
innovation
patents
Amgen's blockbuster hopeful Lumakras sees slower than expected sales in latest data, analyst says
Endpoints
Mon, 07/11/22 - 05:53 pm
Amgen
non-small cell lung cancer
Lumakras
Amgen-backed Kernal Biologics pops off with $25M for mRNA platform
Fierce Biotech
Thu, 07/7/22 - 06:22 pm
Kernal Biologics
MRNA
Amgen
funding
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »